ADAM28 as a Target for Human Cancers
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
2349-2358
Author(s):
Satsuki Mochizuki and Yasunori Okada
Editorial [Hot Topic: Protein Targets in the Treatment of Cancers (Guest Editor: Sabbir Ahmed)]
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
598-598
Author(s):
Sabbir Ahmed
17α-Hydroxylase/17,20-Lyase (P450 ) Inhibitors in the Treatment of Prostate Cancer: A Review
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
613-626
Author(s):
Caroline P. Owen
Advances in Development of Inhibitors of 17β-Hydroxysteroid Dehydrogenases
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
642-660
Author(s):
Donald Poirier
Fibroblast Growth Factors in Development and Cancer: Insights from the Mammary and Prostate Glands
Journal:
Current Drug Targets
Volume:
10
Page:
632-644
Author(s):
Kathryn L. Schwertfeger
Post-Wortmannin Era: Novel Phosphoinositide 3-Kinase Inhibitors with Potential Therapeutic Applications
Journal:
Current Enzyme Inhibition
Volume:
5
Page:
66-86
Author(s):
Laura Braccini, Fulvio Morello, Alessia Perino and Emilio Hirsch
Serine Protease Inhibitor Kazal Type 1 (SPINK1): Beyond the Trypsin Inhibitor
Journal:
Current Enzyme Inhibition
Volume:
5
Page:
110-116
Author(s):
Masaki Ohmuraya, Nobuyuki Ozaki, Masahiko Hirota, Hideo Baba and Ken-ichi Yamamura
Current Status and Perspectives in Peptide Receptor Radiation Therapy
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
2453-2462
Author(s):
Catherine Ansquer, Francoise Kraeber-Bodere and Jean Francoise Chatal
Role of Phase II Drug Metabolizing Enzymes in Cancer Chemoprevention
Journal:
Current Drug Metabolism
Volume:
10
Page:
595-616
Author(s):
Snehasis Jana and Sandhya Mandlekar
Mechanism of Action of Flavonoids as Anti-inflammatory Agents: A Review
Journal:
Inflammation & Allergy - Drug Targets (Discontinued)
Volume:
8
Page:
229-235
Author(s):
Permender Rathee, Hema Chaudhary, Sushila Rathee, Dharmender Rathee, Vikash Kumar and Kanchan Kohli